José María Sayagues Manzano-rekin lankidetzan egindako argitalpenak (51)

2023

  1. An amino acid transporter subunit as an antibody-drug conjugate target in colorectal cancer

    Journal of experimental & clinical cancer research : CR, Vol. 42, Núm. 1, pp. 200

2021

  1. Genomic profiling of sporadic liver metastatic colorectal cancer

    Seminars in Cancer Biology, Vol. 71, pp. 98-108

  2. Tracking the antibody immunome in sporadic colorectal cancer by using antigen self-assembled protein arrays

    Cancers, Vol. 13, Núm. 11

2018

  1. Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients

    Oncotarget, Vol. 9, Núm. 35, pp. 24081-24096

  2. Spatio-temporal tumor heterogeneity in metastatic CRC tumors: A mutational-based approach

    Oncotarget, Vol. 9, Núm. 76, pp. 34279-34288

2017

  1. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors

    Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700

2016

  1. Genomic characterization of liver metastases from colorectal cancer patients

    Oncotarget, Vol. 7, Núm. 45, pp. 72908-72922

2015

  1. Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas

    Oncotarget, Vol. 6, Núm. 22, pp. 19070-19086

  2. Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential

    Leukemia, Vol. 29, Núm. 5, pp. 1186-1194

2014

  1. Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcome

    Journal of Molecular Diagnostics, Vol. 16, Núm. 6, pp. 648-659

  2. Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer

    Medicine (United States), Vol. 93, Núm. 26

  3. Emerging Nanotechniques in Proteomics

    Comprehensive Analytical Chemistry (Elsevier B.V.), pp. 137-157

  4. Evaluation of homo- and hetero-functionally activated glass surfaces for optimized antibody arrays

    Analytical Biochemistry, Vol. 450, Núm. 1, pp. 37-45

  5. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer

    Cancer, Vol. 120, Núm. 13, pp. 1948-1959

  6. Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

    Leukemia

  7. Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene

    American Journal of Hematology, Vol. 89, Núm. 3, pp. 288-294

2013

  1. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

    Blood, Vol. 122, Núm. 22, pp. 3591-3598

  2. Genomics and proteomics approaches for biomarker discovery in sporadic colorectal cancer with metastasis

    Cancer Genomics and Proteomics, Vol. 10, Núm. 1, pp. 19-26

  3. Protein arrays: Recent achievements and their application to study the human proteome

    Current Proteomics, Vol. 10, Núm. 2, pp. 83-97

  4. Protein microarrays: Technological aspects, applications and intellectual property

    Recent Patents on Biotechnology, Vol. 7, Núm. 2, pp. 142-152